XML 59 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Parent Company Only Financial Information (Tables)
 12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
Interim Condensed Balance Sheets
Condensed Balance Sheets
December 31
20242023
Assets
Cash on deposit at the Bank$34,498 $25,010 
Investments in subsidiaries156,486 157,671 
Premises and equipment1,140 1,196 
Other assets47,663 47,949 
Total assets$239,787 $231,826 
Liabilities and Shareholders' Equity
Subordinated debt, net of unamortized issuance costs
$29,424 $29,335 
Other liabilities87 89 
Shareholders' equity210,276 202,402 
Total liabilities and shareholders' equity$239,787 $231,826 
Interim Condensed Statements of Income
Condensed Statements of Income
Year Ended December 31
202420232022
Income
Dividends from subsidiaries$22,000 $30,000 $6,000 
Interest income511 191 15 
Other income11 13 14 
Total income22,522 30,204 6,029 
Expenses
Management fee1,188 952 900 
Interest expense1,065 1,065 1,065 
Audit, consulting, and legal fees561 577 522 
Director fees357 408 417 
Other362 354 339 
Total expenses3,533 3,356 3,243 
Income before income tax benefit and equity in undistributed earnings of subsidiaries18,989 26,848 2,786 
Federal income tax benefit626 654 670 
Income before equity in undistributed earnings of subsidiaries19,615 27,502 3,456 
Undistributed earnings of subsidiaries(5,726)(9,335)18,782 
Net income$13,889 $18,167 $22,238 
Interim Condensed Statements of Cash Flows
Condensed Statements of Cash Flows
Year Ended December 31
202420232022
Operating activities
Net income$13,889 $18,167 $22,238 
Adjustments to reconcile net income to cash provided by operations
Undistributed earnings of subsidiaries5,726 9,335 (18,782)
Share-based payment awards476 782 610 
Amortization of subordinated debt issuance costs89 90 87 
Depreciation56 52 50 
Deferred income tax expense (benefit)313 228 (133)
Net changes in:
Other assets(27)(255)1,383 
Other liabilities(2)(199)160 
Net cash provided by (used in) operating activities20,520 28,200 5,613 
Investing activities
Purchase of equity investments— — (250)
Net (purchases) sales of premises and equipment— (77)260 
Net cash provided by (used in) investing activities— (77)10 
Financing activities
Cash dividends paid on common stock(8,147)(8,216)(8,082)
Proceeds from the issuance of common stock1,523 1,617 1,762 
Common stock repurchased(3,076)(3,415)(1,124)
Common stock purchased for deferred compensation obligations(1,332)(1,624)(1,189)
Net cash provided by (used in) financing activities(11,032)(11,638)(8,633)
Increase (decrease) in cash and cash equivalents9,488 16,485 (3,010)
Cash and cash equivalents at beginning of period25,010 8,525 11,535 
Cash and cash equivalents at end of period$34,498 $25,010 $8,525